Multiple Myeloma — Donor Th2 Cells to Prevent Graft-Versus-Host Disease in Bone Marrow Transplants
Citation(s)
Pilot Study of Donor Th2 Cells for the Prevention of Graft-Versus-Host Disease in the Setting of Non-Myeloablative, HLA-Matched Allogeneic Peripheral Blood Stem Cell Transplantation